By  | May 30, 2012 |  1
I particularly enjoyed this article from the WSJ last weekend.  It is a piece you finish and satisfactorily conclude your time was not wasted.  You have gained a new perspective in reexamining a deed, in this case lying, that we all engage in periodically—that we rationalize, trivialize, or justify—for unwelcome reasons we sidestep to achieve […]
By  | May 26, 2012 |  0
In this large multi center study of patients with septic shock, activated protein C (Drotrecogin alpha) did not reduce mortality at 28 or 90 days, compared to placebo (abstract)
By  | May 26, 2012 |  0
In this large multi center study, patients with an unprovoked VTE who had already completed 6-18 months of anticoagulation were randomized to ASA 100mg/day or placebo for 2 years. The risk of recurrent VTE was 11% in the placebo group and 7% in the ASA group (hazard ratio 0.58, CI 0.36 to 0.93), with no […]
By  | May 24, 2012 |  0
In this large single center analysis, the risk of mortality in those discharged AMA was twice as high as those non-AMA, as was the risk of 30 day readmission. When considering the risk of AMA discharges, all efforts should be used to dissuade patients from prematurely leaving (abstract)
By  | May 24, 2012 |  0
This large analysis of claims against US physicians found about half resulted in litigation, most of which for internal medicine were dismissed by the court, and only 3% of which underwent a trial verdict. Of those with a trial verdict, 80% were judged in favor of the physician. Internal medicine physicians fair well in litigation […]
By  | May 24, 2012 |  0
A simple 3 step pathway (early mobilization, criteria for switching to oral antibiotic, and criteria for hospital discharge) in patients with CAP reduced LOS by 2 days, reduced IV antibiotics by 2 days, and reduced the incidence of adverse drug reactions by 11%, with no change in readmission, mortality, or patient satisfaction scores (abstract)